slightli ahead oper adj ep came
ahead estim consensu
compar upsid estim reflect
better expect adj oper margin vs
estim lower revenu lower tax rate ad ep
lower interest expens note
consist expect re-affirmed outlook adj
oper profit growth
first time provid adj ep outlook
exclud interest expens aetna-rel debt note
repres chang prior commentari call
continu highlight merit plan aet acquisit still
expect close creat integr health care
platform well recent innov focus improv
qualiti lower cost health care threat
wane improv oper metric rel attract
valuat continu see upsid share reiter
outperform rate rais adj ep estim
respect leav
price target unchang assum price-to-earnings
oper profit growth expect front half weight
contrast prior commentari cite expect oper
growth concentr first half year given
earlier expect progress certain pharmaci initi lower
previous expect growth long term ramp
relat implement cost million plan
invest tax save primarili regard
cite on-going reimburs pressur lower benefit
cost improv effort well assist live initi
combin drove lower growth outlook
lower rfp activ pbm pharmaci benefit manag
sell season note halfway
client renew retent rate line prior year
also indic expect rfp opportun less
prior sell season note convers
health plan construct posit discuss
aetna transact potenti servic enhanc
same-stor ss sale growth rose
pressur restrict network turn posit
anniversari neg chang past note flu
ad million adjust script growth bp ss front-end
sale bp exclud flu adjust script still rose
yr/yr led continu adopt patient program pbm/
health plan partnership prefer posit medicar
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
adjust exclud intang amort one-tim item quarterli ep
may add due share repurchas
compani prioriti stock list
compani data secur llc estim reuter
earn outlook reiter enterpris adjust oper profit growth
improv net revenu growth outlook rang previous
also provid first time adjust ep outlook enterpris wide financi
guidanc metric includ tax rate unchang adjust net interest expens
billion retail/ltc segment adjust oper profit year expect declin low
singl digit rang unchang net revenu growth vs previous same-
store sale growth same-stor adjust script growth
pharmaci servic segment adjust oper profit year expect
low-to-mid singl digit rang unchang net revenu growth unchang total
adjust claim billion billion
provid adjust ep outlook reflect net revenu growth
adjust oper profit growth flat growth mid-to-high singl digit rang
retail/ltc declin mid-to-high singl digit rang pharmaci servic
aetna transact progress plan manag note regulatori approv process
progress within expect time-frame reiter expect transact close
latter half year still respond second request work aet
integr plan believ state approv seem slow pace note state
requir hear start schedul hold hear start receiv approv
state includ fl april
key takeaway cite signific progress enterpris streamlin effort
alreadi start bear fruit expect gener roughli million gross benefit
million run rate basi work complet regard point sale rebat
cite expect increas interest point sale rebat given continu growth high deduct
health plan note million member point sale program current
adopt slow expect rebat notabl impact margin though
provid opportun lower cost member manag note rebat
go back payer prior commentari
summari quarterli incom statement well fargo million except y/yfisc year end decemb changeselect commentarypharmaci servic adj claim rose pharmacy/ltc yr/yr pharmaci servic retail pharmacy/ltc interest expens loss divestitur interest expens relat aet debt tax continu discontinu oper net loss attribut non-controlling incom attribut continu averag share total compstore pharmaci compstore front store compstore adjust claim health corp
million unless otherwis profit ep servic pbm adjust prescript choic penetr dispens rate profit per adjust pharmaci long-term adj retail prescript gener dispens store sale pharmaci store sale front profit health servic
compani report secur llc
note adjust ep exclud intang amort one-tim item
compani report secur llc
compani report secur llc
ep adjust ep revenu billion pharmaci servicesretail pharmaci profit yoy growth corp
compani report secur llc
compani report secur llc
compani report secur llc
profit marginpharmaci servic gpmretail pharmaci profit marginpharmaci servic opmretail pharmaci profit million pharmaci servic oper profitretail pharmaci oper profit servic
compani report secur llc
note chang adjust claim methodolog better reflect retail prescript adjust
claim mail penetr rate prior shown base old methodolog
compani report secur llc
compani report secur llc
note chang adjust claim methodolog better reflect retail prescript adjust
claim prior shown base old methodolog
compani report secur llc
compani report secur llc
compani report secur llc
store sale compstore growthpharmaci sssfront store ssstotal revenu billion pharmacyfront claim million adjust claimsgener dispens rate
health quarterli incom statement million except per share dec expens tax continu discontinu oper net loss attribut non-controlling incom attribut averag continu tax servic segment adjust claim volum gener dispens rate ebitda per adj oper oper profit margin retail pharmacy/ltc segment adj retail prescript fill gener dispens rate net oper oper profit margin margin analysisgross changenet secur llc estim compani
exhibit balanc sheet statement
health balanc sheet health statement flow millionsestimatedestim flow oper activ current assetsnet cash receiv incom tax non-cash incom oper asset current receiv current current equip asset long-term cash provid oper sharehold equiti flow invest activ current liabil addit properti sale-lease-back discount net cash acquir short-term sale matur short-term portion long-term sale dispos current cash provid invest incom flow financ activ long-term decreas short-term non-controlling debt assum liabil long-term long-term exercis stock held tax benefit stock-bas common cash provid financ sharehold liabil sharehold chang cash cash equival restrict chang restrict secur llc estim compani report cash equival cash equival secur llc estim compani report health servic
price target nc
price target health base price-to-earnings multipl time ep estim
risk includ continu need capit spend maintain store grow new busi
compet custom supplier increas price transpar competit price pressur
abil complet success integr plan acquisit aet
rate share outperform believ posit weather chang pbm/retail
pharmaci busi increas use narrow network price transpar competit
pressur believ vertic structur abil dispens drug channel posit
futur also plan acquisit aet creat integr healthcar platform better
posit competit threat
headquart woonsocket rhode island one largest pharmaci dispens
pharmaci benefit manag countri leader retail pharmaci oper store
unit state puerto rico brazil also leader dispens pharmaceut
institut omnicar busi acquir home coram
busi acquir mail via caremark acquir
recent acquisit in-stor pharmaci also provid greater distribut network
gener approxim billion revenu increas year-over-year
billion net earn
